Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study
European Journal of Cancer, 03/18/09
Ludwig H et al. - Treatment patterns were guideline congruent, except for (intravenous) iron supplementation. Hb increased by 1.34 g/dl. A net erythropoiesis boost of Hb > 1 g/dl is attainable in two-thirds of patients and should be condensed to 8 weeks on an individual patient basis. Anaemia management in Europe has improved significantly. The general effectiveness and relative safety of judicious ESA treatment are evident.
Related Articles
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09
Relevance Score: 67%
Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia
Bone Marrow Transplantation, 10/15/09
Relevance Score: 64%
Blood counts are clues to human disease
EurekAlert, 10/12/09
Relevance Score: 64%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 49%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 48%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia
Hematology, 12/03/09
The expanding spectrum of thalassemia intermedia
Hematology, 12/03/09
Reference percentiles of hematological and biochemical iron values of blood donors in Port Harcourt, Nigeria
Hematology, 12/03/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: A prospective, multi-center phase III study
Blood, 12/03/09
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, 12/03/09
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
British Journal of Cancer, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


